BioSpace News Archive

Amy Abernethy, the chief medical officer of Roche-owned Flatiron Health, has been named the Principal Deputy Commissioner of Food and Drugs at the U.S. Food and Drug Administration.

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

Sareum Holdings plc (AIM: SAR), the specialist small molecule drug development business, will be holding its Annual General Meeting today, at 10:00 at the offices of Citigate Dewe Rogerson, 3 London Wall Buildings, London Wall, London EC2M 5SY. The Chairman, Dr Stephen Parker will make the following statement:

Maintaining a high negative pressure in airborne infection isolation rooms of hospitals (over -10 Pa) and in renovation sites (over -5 Pa) effectively limits the dispersion of airborne contaminants and dust, a new study from the University of Eastern Finland shows.

Although Sophiris Bio plans to continue development, investors weren’t enthused, letting stock plunge more than 38 percent after the company released mixed results from its Phase IIb clinical trial of topsalysin in prostate cancer.

Are you reluctant to bring up a salary increase over the holiday season? Don’t be! In fact, the holidays are an excellent time to ask your employer for a promotion, and here’s why.

Healthtech will rise to prominence in 2019 as Big Data and Artificial Intelligence (AI) become a transformational force in healthcare, says GlobalData, a leading data and analytics company.

Following the announcement of positive results from Janssen’s Phase III open label long- term extension study, which evaluates the efficacy and safety data of Stelara in Crohn’s Disease (CD),

Company to supply a six months’ stock of ready-to-use medicines in the event of an emergency

Days before Christmas, three new companies decided to strip away the wrapping paper and unveil themselves to the world. Each of the companies launched with millions of dollars raised through a Series A financing round.